Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Riel, J. M. G. H.
Right arrow Articles by Giaccone, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Riel, J. M. G. H.
Right arrow Articles by Giaccone, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 11:1563-1570, 2000
© 2000 European Society for Medical Oncology

research-article

Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: Single-centre experience in 145 patients

J. M. G. H. van Riel1,, C. J. van Groeningen1, S. H. M. Albers1, M. Cazemier1, S. Meijer2, R. Bleichrodt2, F. G. van den Berg3, H. M. Pinedo1 and G. Giaccone1

1Department of Medical Oncology, University Hospital Vrije Universiteit Amsterdam, The Netherlands
2Department of Surgical Oncology, University Hospital Vrije Universiteit Amsterdam, The Netherlands
3Department of Radiology, University Hospital Vrije Universiteit Amsterdam, The Netherlands

Correspondence to: J. M. G. H. van Riel, MD Department of Medical Oncology University Hospital Vrije Universiteit De Boelelaan 1117 1081 HV Amsterdam The Netherlands E-mail: JMGH.vRiel{at}azvu.nl

Background: Hepatic arterial chemotherapy for liver metastases of colorectal cancer is still under discussion. Mainly because of the technical complications of this mode of treatment and the lack of a survival benefit in randomized studies. We performed an analysis of hepatic arterial 5-fluorouracil (5-FU) chemotherapy in 145 consecutive patients treated at a single institution.

Patients and methods: One hundred forty-five patients with inoperable liver metastases from colorectal cancer were included. 5-FU, 1000 mg/m2/day continuous infusion for five days every three weeks, was delivered in the hepatic artery by percutaneous catheter or arterial access device.

Results: The response rate was 34% for all patients, 40% in patients with extrahepatic disease, and 15% in patients with i.v. 5-FU-based pretreatment. TTP and OS for all patients were 7.5 and 14.3 months, respectively. In patients with extrahepatic disease or i.v. 5-FU-based pretreatment, OS was significantly shorter compared to patients without extrahepatic disease or 5-FU-based pretreatment (9.7 vs. 19.3 months and 10.1 vs. 17.4 months, respectively). forty-seven percent of patients stopped treatment because of a complication. Complications most often seen in patients with arterial ports were hepatic artery thrombosis (48%) and dislocation of the catheter (22%).

Conclusions: The results of our analysis are in line with previous phase III studies. Extrahepatic disease and i.v. 5-FU-based pretreatment were prognostic for reduced OS. The complication rate of hepatic arterial delivery was worrisome, although, no negative impact on survival could be established. There is a strong need for improvement of hepatic arterial delivery methods before further evaluation of hepatic arterial 5-FU will be worthwhile.

5-fluorouracil, arterial access device, chemotherapy, colorectal cancer, hepatic arterial chemotherapy, liver metastases, port-a-cath


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
P. Noordhuis, U. Holwerda, C. L. Van der Wilt, C. J. Van Groeningen, K. Smid, S. Meijer, H. M. Pinedo, and G. J. Peters
5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers
Ann. Onc., July 1, 2004; 15(7): 1025 - 1032.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J. M. G. H. van Riel, C. J. van Groeningen, J. de Greve, G. Gruia, H. M. Pinedo, and G. Giaccone
Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver
Ann. Onc., January 1, 2004; 15(1): 59 - 63.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.